Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Mar 1;336(7642):458-9.
doi: 10.1136/bmj.39499.514410.80.

Safety of very tight blood glucose control in type 2 diabetes

Editorial

Safety of very tight blood glucose control in type 2 diabetes

Philip Home. BMJ. .

Abstract

Aim for glycated haemoglobin lower than 6.5%, but without using highly intensive treatment

PubMed Disclaimer

Conflict of interest statement

Competing interests: Institutions associated with PH receive funding from all the major manufacturers of oral agents and insulin regarding his educational, consultative, and research activities.

Comment in

References

    1. National Heart, Lung, and Blood Institute. For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease. 2008. http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2551
    1. Clinical Guidelines Task Force. Global guideline for the management of type 2 diabetes Brussels, International Diabetes Federation, 2005. www.idf.org/home/index.cfm?node=1457
    1. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 2007;51:8-11. - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65. - PubMed

Publication types

MeSH terms